Mirum Pharmaceuticals, Inc. (MIRM)

Mirum Pharmaceuticals Stock Forecast

Stock Price Forecast

According to 11 professional analysts, the 12-month price target for Mirum Pharmaceuticals stock ranges from a low of $55 to a high of $95. The average analyst price target of $82.82 forecasts a 20.94% increase in the stock price over the next year.

Price Target: $82.82 (+20.94%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$55	$82.82	$82	$95
Change	-19.68%	+20.94%	+19.74%	+38.73%

* Price targets were last updated on Nov 5, 2025.

Analyst Ratings

The average analyst rating for Mirum Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	5	5	6	6	6	5
Buy	7	4	5	6	6	6
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	12	9	11	12	12	11

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Josh Schimmer Cantor Fitzgerald	Cantor Fitzgerald	Buy Maintains $85 → $95	Buy	Maintains	$85 → $95	+38.73%	Nov 5, 2025
Jonathan Wolleben Citizens	Citizens	Buy Maintains $81 → $95	Buy	Maintains	$81 → $95	+38.73%	Nov 5, 2025
Swayampakula Ramakanth HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $80 → $81	Strong Buy	Maintains	$80 → $81	+18.28%	Nov 5, 2025
Michael Ulz Morgan Stanley	Morgan Stanley	Buy Maintains $75 → $81	Buy	Maintains	$75 → $81	+18.28%	Oct 16, 2025
Joseph Thome TD Cowen	TD Cowen	Strong Buy Initiates $95	Strong Buy	Initiates	$95	+38.73%	Sep 24, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

518.07M

Increased by 53.78%

from 336.89M

Revenue Next Year

621.23M

Increased by 19.91%

from 518.07M

EPS This Year

-0.39

from -1.85

EPS Next Year

0.34

from -0.39

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	19.14M	77.06M	186.37M	336.89M	518.07M	621.23M
Revenue Growth	-	-	302.67%	141.85%	80.76%	53.78%	19.91%
EPS	-4.09	-2.77	-4.02	-4.00	-1.85	-0.39	0.34
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	201.55
No. Analysts	-	-	-	-	-	13	13

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	536.6M	692.6M
Avg	518.1M	621.2M
Low	493.9M	562.6M

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	59.3%	33.7%
Avg	53.8%	19.9%
Low	46.6%	8.6%

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	-0.19	1.02
Avg	-0.39	0.34
Low	-0.53	-0.38

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.